Header Logo

Paul Rubinstein

Concepts (21)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Paul Rubinstein's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Paul Rubinstein has written about over time.
Anti-HIV Agents, 1 publications between 2012 and 2012, average publication date August 2012. HIV Seropositivity, 1 publications between 2012 and 2012, average publication date August 2012. Immunosuppressive Agents, 1 publications between 2012 and 2012, average publication date August 2012. Multiple Myeloma, 1 publications between 2012 and 2012, average publication date August 2012. Stomatitis, Aphthous, 1 publications between 2012 and 2012, average publication date August 2012. Thalidomide, 1 publications between 2012 and 2012, average publication date August 2012. Venous Thrombosis, 1 publications between 2012 and 2012, average publication date August 2012. Humans, 2 publications between 2012 and 2023, average publication date April 2018. Middle Aged, 2 publications between 2012 and 2023, average publication date April 2018. Cyclophosphamide, 1 publications between 2023 and 2023, average publication date November 2023. Doxorubicin, 1 publications between 2023 and 2023, average publication date November 2023. Etoposide, 1 publications between 2023 and 2023, average publication date November 2023. Lactate Dehydrogenases, 1 publications between 2023 and 2023, average publication date November 2023. Lymphoma, Large B-Cell, Diffuse, 1 publications between 2023 and 2023, average publication date November 2023. Prednisone, 1 publications between 2023 and 2023, average publication date November 2023. Proto-Oncogene Proteins c-bcl-2, 1 publications between 2023 and 2023, average publication date November 2023. Proto-Oncogene Proteins c-myc, 1 publications between 2023 and 2023, average publication date November 2023. Retrospective Studies, 1 publications between 2023 and 2023, average publication date November 2023. Rituximab, 1 publications between 2023 and 2023, average publication date November 2023. Vincristine, 1 publications between 2023 and 2023, average publication date November 2023.

To see the data from this visualization as text, click here.
Rubinstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (21)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_